Intravenous thrombolysis in acute ischemic stroke after dabigatran reversal with idarucizumab–a case report
JS Mutzenbach, S Pikija, F Otto… - Annals of clinical …, 2016 - Wiley Online Library
Much excitement has been generated with the approval of idarucizumab, a humanized
monoclonal antigen‐binding antibody fragment that is capable of reversing the …
monoclonal antigen‐binding antibody fragment that is capable of reversing the …
[引用][C] Intravenous thrombolysis in acute ischemic stroke after dabigatran reversal with idarucizumab–a case report
JS Mutzenbach, S Pikija, F Otto, U Halwachs… - Annals of Clinical and …, 2016 - cir.nii.ac.jp
Intravenous thrombolysis in acute ischemic stroke after dabigatran reversal with idarucizumab
– a case report | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …
– a case report | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …
Intravenous thrombolysis in acute ischemic stroke after dabigatran reversal with idarucizumab-a case report
JS Mutzenbach, S Pikija, F Otto… - Annals of clinical …, 2016 - pubmed.ncbi.nlm.nih.gov
Much excitement has been generated with the approval of idarucizumab, a humanized
monoclonal antigen-binding antibody fragment that is capable of reversing the anticoagulant …
monoclonal antigen-binding antibody fragment that is capable of reversing the anticoagulant …
[PDF][PDF] Intravenous thrombolysis in acute ischemic stroke after dabigatran reversal with idarucizumab-a case report
JS Mutzenbach, S Pikija, F Otto… - Annals of Clinical …, 2016 - mediatum.ub.tum.de
Much excitement has been generated with the approval of idarucizumab, a humanized
monoclonal antigen-binding antibody fragment that is capable of reversing the anticoagulant …
monoclonal antigen-binding antibody fragment that is capable of reversing the anticoagulant …
[HTML][HTML] Intravenous thrombolysis in acute ischemic stroke after dabigatran reversal with idarucizumab–a case report
JS Mutzenbach, S Pikija, F Otto… - Annals of Clinical and …, 2016 - ncbi.nlm.nih.gov
Much excitement has been generated with the approval of idarucizumab, a humanized
monoclonal antigen‐binding antibody fragment that is capable of reversing the …
monoclonal antigen‐binding antibody fragment that is capable of reversing the …
[PDF][PDF] Intravenous thrombolysis in acute ischemic stroke after dabigatran reversal with idarucizumab–a case report
JS Mutzenbach, S Pikija, F Otto, U Halwachs… - …, 2016 - scienceopen.com
Much excitement has been generated with the approval of idarucizumab, a humanized
monoclonal antigen-binding antibody fragment that is capable of reversing the anticoagulant …
monoclonal antigen-binding antibody fragment that is capable of reversing the anticoagulant …
Intravenous thrombolysis in acute ischemic stroke after dabigatran reversal with idarucizumab–a case report
JS Mutzenbach, S Pikija, F Otto… - Annals of Clinical …, 2016 - search.proquest.com
Much excitement has been generated with the approval of idarucizumab, a humanized
monoclonal antigen‐binding antibody fragment that is capable of reversing the …
monoclonal antigen‐binding antibody fragment that is capable of reversing the …
Intravenous thrombolysis in acute ischemic stroke after dabigatran reversal with idarucizumab-a case report.
JS Mutzenbach, S Pikija, F Otto… - Annals of Clinical and …, 2016 - europepmc.org
Much excitement has been generated with the approval of idarucizumab, a humanized
monoclonal antigen‐binding antibody fragment that is capable of reversing the …
monoclonal antigen‐binding antibody fragment that is capable of reversing the …